19 May 2023

GSK Stockmann contributed to the publication of the IFLR China Outbound Report

The new edition of the China Outbound Report has been published by the International Financial Law Review (IFLR); IFLR has partnered with leading advisors to share their knowledge and vision for Chinese outbound investment.

First published in 1982, IFLR is the industry’s source on corporate finance trends and strategies, with informed viewpoints from a network of global editors, journalists and contributors from leading law firms and corporate counsels.

GSK Stockmann contributed to the guide: Dr. Marcus Peter (Partner at GSK Stockmann in Luxembourg) and Kate Yu Rao (Senior Associate at GSK Stockmann in Luxembourg) composed the article “Chinese investments continue to advance in Luxembourg markets” illustrating the most recent legal and regulatory developments impacting Chinese investments into Luxembourg.

This article was originally published by IFLR and is available for download as a PDF file and free to access on the IFLR website.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 06.04.2023

    GSK Update: Bill of Law: Modernising the Luxembourg Investment Funds Toolbox

    Read more
  • 27.03.2023

    GSK Update: Hierarchy of Banks’ Liabilities

    Read more
  • 22.03.2023

    GSK Update: DLT Pilot Regime and Blockchain III Law

    Read more
Contact person

Dr. Marcus Peter, LL.M. eur.

Partner

+352 271802-50

marcus.peter@gsk-lux.com

Kate Rao, LL.M.

Senior Associate

+352 271802-54

kate.rao@gsk-lux.com

© GSK Stockmann 2023